Chittaranjan National Cancer Institute
Kolkata, West Bengal, India
Hospital in Kolkata, West Bengal
37, Shyama Prasad Mukherjee Rd, Bakul Bagan, Bhowanipore, Kolkata, West Bengal 700026
About Chittaranjan National Cancer Institute
Chittaranjan National Cancer Institute is a cancer care hospital & Research Institute and one of the 25 Regional Cancer Centres in India. It is located in Kolkata near Jatin Das Park metro station at Hazra More.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
1
Boehringer Ingelheim
1
Cadila Pharnmaceuticals
1
Merck KGaA, Darmstadt, Germany
1
Morphotek
1
Mylan Pharmaceuticals Inc
1
Spectrum Pharmaceuticals, Inc
1
Sun Pharma Advanced Research Company Limited
1
Thinq Pharma-CRO Pte. Ltd.
1
University of Louisville
1
Clinical Trials at Chittaranjan National Cancer Institute
During the past decade, Chittaranjan National Cancer Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer
2008-06-01
2010-12-01
Completed
221
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
2009-11-30
2014-08-05
Terminated
165
Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
2012-06-19
2013-04-15
Terminated
18
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
2015-09-30
2025-10-31
Recruiting
204
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment Refractory/Intolerant CML Failing ≥3 Prior CML Therapies
2017-04-25
2026-08-01
Recruiting
303
A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis.
2016-12-01
2018-11-01
Unknown status
360
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Chittaranjan National Cancer Institute" #1 sponsor was "Bayer" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials
sponsored, "Cadila Pharnmaceuticals" with 1 trials sponsored, "Merck KGaA, Darmstadt, Germany" with 1 trials sponsored and "Morphotek"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Chittaranjan National Cancer Institute"
#1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "James Graham Brown Cancer Center" with 1 trials as a collaborator, "Merck Ltd., India" with 1 trials as a collaborator, "THINQ Pharma CRO Ltd." with 1 trials as a collaborator and "Unique Pharmaceuticals Ltd, India" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Chittaranjan National Cancer Institute
According to Clinical.Site data, the most researched conditions in "Chittaranjan National Cancer Institute" are
"Cervical Cancer" (1 trials), "Chronic Myeloid Leukemia (for Part B and C)" (1 trials), "Colorectal Neoplasms" (1 trials), "Glioblastoma Multiforme" (1 trials) and "Healthy (For Part A)" (1 trials). Many other conditions were trialed in "Chittaranjan National Cancer Institute" in a lesser frequency.
Clinical Trials Intervention Types at Chittaranjan National Cancer Institute
Most popular intervention types in "Chittaranjan National Cancer Institute" are "Drug" (8 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "BAY2757556 (Larotrectinib, Vitrakvi)" (1 trials), "Bevacizumab as Avastin" (1 trials), "Bevacizumab as MYL-1402O" (1 trials), "Carboplatin" (1 trials) and "Cetuximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chittaranjan National Cancer Institute
The vast majority of trials in "Chittaranjan National Cancer Institute" are
8 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Chittaranjan National Cancer Institute
Currently, there are NaN active trials in "Chittaranjan National Cancer Institute".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Chittaranjan National Cancer Institute,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Chittaranjan National Cancer Institute, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".